Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Antisecretory Factor In Severe Traumatic Brain Injury — Stella

Home/Traumatic Brain Injury/Antisecretory Factor In Severe Traumatic Brain Injury

View on ClinicalTrials.gov

Recruiting

Back to Traumatic Brain Injury trials

Antisecretory Factor In Severe Traumatic Brain Injury

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Sweden

Skane University Hopsital, Lund

Key details

Phase

Safety & dosing

Sponsor

Peter Siesjö

Collaborators

Skane University Hospital, Lantmannen Medical AB

Enrollment target

~20 participants

Started

March 2020

Primary completion

December 2026

Age range

10 Years – 70 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.